A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes

Rascol, O, CJ Fitzer-Attas, RA Hauser, J Jankovic, A Lang, JW Langston, E Melamed, et al. 2011. “A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson’s Disease (the ADAGIO Study): Prespecified and Post-Hoc Analyses of the Need for Additional Therapies, Changes in UPDRS Scores, and Non-Motor Outcomes”. Lancet Neurol.
Last updated on 11/04/2024